结合,中和和内部化的互乐金-13抗体,莱布里基祖马布
Angela J Okragly1, Aya Ryuzoji2, Isabella Wulur3
1Immunology Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 46285, USA. okragly_angela@lilly.com.
Dermatology and therapy
|June 13, 2023
概括
与其他单克隆抗体相比,勒布里奇祖马布在中和介素-13 (IL-13) 中具有优越的结合亲和力和强度. 它独特的作用机制可能解释了它在亚托皮性皮肤炎的临床疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 互乐金-13 (IL-13) 是亚托皮性皮肤炎 (AD) 发病的一个关键细胞因子.
- 治疗性单克隆抗体 (mAbs) 如lebrikizumab,tralokinumab和sendaakimab针对IL-13用于AD治疗.
研究的目的:
- 为了比较三种针对IL-13的mAbs:lebrikizumab,tralokinumab和 cendakimab的体外结合亲缘关系和功能活动.
- 阐明这些治疗抗体的独特作用机制.
主要方法:
- 使用表面等离子体共振 (SPR) 来评估结合亲和力和脱离率.
- 基于细胞的测试 (STAT6报告员,纤维细胞质蛋白分泌) 评估了中和功效.
- 同焦显微镜通过IL-13Rα2.2.追踪IL-13/mAb复合体内部化通过IL-13Rα2.
主要成果:
- 勒布里基祖马布表现出较高的结合亲和力和较慢的解离率与IL-13,而不是tralokinumab或 cendakimab.
- 勒布里基祖马布在中和IL-13-介导的细胞反应方面表现出更大的效力.
- 只有IL-13 / lebrikizumab复合体经历了内部化和与溶解体的同局部化,与其他复合体不同.
结论:
- 勒布里基祖马布是一种高亲和力,强大的中和抗体,对IL-13具有缓慢解离率.
- 勒布里基祖马布的独特机制,包括细胞内化,可能有助于其在亚托皮炎中观察到的临床疗效.
- 这项研究突显了IL-13向mAbs的独特功能差异.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
177
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
177
Antibody Actions
1.2K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.2K
Antiasthma Drugs: Leukotriene Modifiers
372
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
372
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K


